Tweet
HEMOPHILIA PATIENTS FACE DRUG SHORTAGE IN ARMENIA
13:47 ~U 17.04.13
The Armenian Association for Patients with Hemophilia has difficulty
in supplying beneficiaries with necessary drugs, the organization's
president has said.
At a news conference on Wednesday, Tanya Khachatryan expressed
concerns over the the low drug quantity which often affects the
treatment effectiveness.
"As a developing country, we draw parallels with other states, and we
observe a low rate of drug supply. We are hopeful that the government
will pay a due attention to the problem, because a preventive treatment
with drugs is much more effective," she noted.
Khachatryan said that 70% of the hemophilia patients in Armenia have
a disability status. She noted further that Minister of Health Derenik
Demirchyan has promised to ensure the necessary supply of drugs.
"Ministers, unfortunately, change very often here, and we every
time start things from scratch. And once we reach a certain point,
the minister is replaced," she said.
Smbat Daghbashayn, Armenia's chief hematologist also attending the
news conference, noted for his part that the medicines for hemophilia
patients are very expensive and often obtained from blood donors
whose number is very low in Armenia. He said the society too, has to
be interested in the problem and agree to be a blood donor for those
who are ill.
"The surgery is performed in the frameworks of government funding,
with each intervention costing $50,000. Our centers performed around
20,000 operations in the past four years," he said, adding that the
necessary supply of drugs could help a patient avoid a surgery.
"If there are drugs, we can perform more operations," Daghbashayn
added.
Both specialists confirmed at the end that 30 hemophilia patients
are now in need of a surgical intervention in Armenia.
http://www.tert.am/en/news/2013/04/17/hemofilia/
13:47 ~U 17.04.13
The Armenian Association for Patients with Hemophilia has difficulty
in supplying beneficiaries with necessary drugs, the organization's
president has said.
At a news conference on Wednesday, Tanya Khachatryan expressed
concerns over the the low drug quantity which often affects the
treatment effectiveness.
"As a developing country, we draw parallels with other states, and we
observe a low rate of drug supply. We are hopeful that the government
will pay a due attention to the problem, because a preventive treatment
with drugs is much more effective," she noted.
Khachatryan said that 70% of the hemophilia patients in Armenia have
a disability status. She noted further that Minister of Health Derenik
Demirchyan has promised to ensure the necessary supply of drugs.
"Ministers, unfortunately, change very often here, and we every
time start things from scratch. And once we reach a certain point,
the minister is replaced," she said.
Smbat Daghbashayn, Armenia's chief hematologist also attending the
news conference, noted for his part that the medicines for hemophilia
patients are very expensive and often obtained from blood donors
whose number is very low in Armenia. He said the society too, has to
be interested in the problem and agree to be a blood donor for those
who are ill.
"The surgery is performed in the frameworks of government funding,
with each intervention costing $50,000. Our centers performed around
20,000 operations in the past four years," he said, adding that the
necessary supply of drugs could help a patient avoid a surgery.
"If there are drugs, we can perform more operations," Daghbashayn
added.
Both specialists confirmed at the end that 30 hemophilia patients
are now in need of a surgical intervention in Armenia.
http://www.tert.am/en/news/2013/04/17/hemofilia/